C4 Therapeutics, Inc.
USD3.58
-0.11 (-2.98%)
CEO
Andrew J. Hirsch
IPO Date
2020-10-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.71
Prev. Close
$3.69
Day Low
$3.48
Day High
$3.73
52W Low
$1.69
52W High
$5.17
Market Cap
$0.30B
Volume
3.13M
| 7,397 |
| $4.06 |
| 2 Jul 2026 | Anderson Kenneth Carl | director | A-Award | Acquired | 2,650 | $4.34 |
| 2 Jul 2026 | GROGAN DONNA ROY | director | A-Award | Acquired | 3,341 | $4.34 |
| 26 Jun 2026 | Hughes Owen | director | A-Award | Acquired | 62,000 | $4.25 |
| 26 Jun 2026 | Hoerter Steven L. | director | A-Award | Acquired | 62,000 | $4.25 |
| 26 Jun 2026 | Koppikar Utpal | director | A-Award | Acquired | 62,000 | $4.25 |
| 26 Jun 2026 | Anderson Kenneth Carl | director | A-Award | Acquired | 62,000 | $4.25 |
| 26 Jun 2026 | Cooper Ronald Harold Wilfred | director | A-Award | Acquired | 62,000 | $4.25 |
| 26 Jun 2026 | Bessen Laura | director | A-Award | Acquired | 62,000 | $4.25 |